These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17414222)

  • 41. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.
    Abe K; Shimokawa H; Morikawa K; Uwatoku T; Oi K; Matsumoto Y; Hattori T; Nakashima Y; Kaibuchi K; Sueishi K; Takeshit A
    Circ Res; 2004 Feb; 94(3):385-93. PubMed ID: 14670839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic potential of rho-kinase inhibitors in cardiovascular diseases.
    Hirooka Y; Shimokawa H
    Am J Cardiovasc Drugs; 2005; 5(1):31-9. PubMed ID: 15631536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Rho-kinase inhibitor on vasopressin-induced chronic myocardial damage in rats.
    Satoh Si; Ikegaki I; Toshima Y; Watanabe A; Asano T; Shimokawa H
    Life Sci; 2002 Nov; 72(1):103-12. PubMed ID: 12409149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angina pectoris caused by coronary microvascular spasm.
    Mohri M; Koyanagi M; Egashira K; Tagawa H; Ichiki T; Shimokawa H; Takeshita A
    Lancet; 1998 Apr; 351(9110):1165-9. PubMed ID: 9643687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats.
    Okamura N; Saito M; Mori A; Sakamoto K; Kametaka S; Nakahara T; Ishii K
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):207-12. PubMed ID: 17593003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors.
    Fukumoto Y; Tawara S; Shimokawa H
    Tohoku J Exp Med; 2007 Apr; 211(4):309-20. PubMed ID: 17409670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Hirai S; Seto M; Satoh S; Ohtomo E;
    J Neurol Sci; 2005 Nov; 238(1-2):31-9. PubMed ID: 16005902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo.
    Slotta JE; Braun OO; Menger MD; Thorlacius H
    Inflamm Res; 2006 Sep; 55(9):364-7. PubMed ID: 17122957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo.
    Miyata K; Shimokawa H; Kandabashi T; Higo T; Morishige K; Eto Y; Egashira K; Kaibuchi K; Takeshita A
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2351-8. PubMed ID: 11073837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies.
    Satoh S; Ikegaki I; Kawasaki K; Asano T; Shibuya M
    Curr Vasc Pharmacol; 2014; 12(5):758-65. PubMed ID: 24923440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia.
    Kikuchi Y; Takahashi J; Hao K; Sato K; Sugisawa J; Tsuchiya S; Suda A; Shindo T; Ikeda S; Shiroto T; Matsumoto Y; Miyata S; Sakata Y; Shimokawa H
    Int J Cardiol; 2019 Dec; 297():8-13. PubMed ID: 31611086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm.
    Dong M; Yan BP; Yu CM
    Cardiovasc Hematol Agents Med Chem; 2009 Oct; 7(4):322-30. PubMed ID: 19607644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained elevation of serum cortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo: a possible link between stress and coronary vasospasm.
    Hizume T; Morikawa K; Takaki A; Abe K; Sunagawa K; Amano M; Kaibuchi K; Kubo C; Shimokawa H
    Circ Res; 2006 Sep; 99(7):767-75. PubMed ID: 16960099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.
    Sun GP; Kohno M; Guo P; Nagai Y; Miyata K; Fan YY; Kimura S; Kiyomoto H; Ohmori K; Li DT; Abe Y; Nishiyama A
    J Am Soc Nephrol; 2006 Aug; 17(8):2193-201. PubMed ID: 16790507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Beneficial effects of diltiazem in exertion stable angina. Evaluation of coronary hemodynamics during cardiac pacing].
    Vigorito C; Giordano A; De Caprio L; Vitale D; Ferrara N; Canonico V; Silvestri P; Casaburi E; Ferraro P; Rengo F
    G Ital Cardiol; 1986 Dec; 16(12):1032-6. PubMed ID: 3556941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
    Anegawa G; Kawanaka H; Yoshida D; Konishi K; Yamaguchi S; Kinjo N; Taketomi A; Hashizume M; Shimokawa H; Maehara Y
    Hepatology; 2008 Mar; 47(3):966-77. PubMed ID: 18167063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Smoking, endothelial function, and Rho-kinase in humans.
    Noma K; Goto C; Nishioka K; Hara K; Kimura M; Umemura T; Jitsuiki D; Nakagawa K; Oshima T; Chayama K; Yoshizumi M; Higashi Y
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2630-5. PubMed ID: 16210569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats.
    Fukui S; Fukumoto Y; Suzuki J; Saji K; Nawata J; Tawara S; Shinozaki T; Kagaya Y; Shimokawa H
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):317-26. PubMed ID: 18356698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure.
    Kishi T; Hirooka Y; Masumoto A; Ito K; Kimura Y; Inokuchi K; Tagawa T; Shimokawa H; Takeshita A; Sunagawa K
    Circulation; 2005 May; 111(21):2741-7. PubMed ID: 15927989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.